Skip to main content

Basal Cell Carcinoma of the Extremity

  • Chapter
  • First Online:
Uncommon Ulcers of the Extremities
  • 130 Accesses

Abstract

Chronic ulcers affecting the extremities have diverse etiology. These ulcers are more common in the lower extremity than in the upper extremity. The prevalence of lower extremity ulcers ranges from 0.18% to 2% but increases to 5% in patients older than 65 years [1]. Some of the common extremity ulcers include diabetic foot ulcers, ulcers of chronic venous disease, ischemic ulcers, chronic infections such as tuberculosis, autoimmune diseases, and malignant ulcers. Of the various types of ulcers mentioned above, malignant ulcers are relatively uncommon. These ulcers can be either primary or result from malignant transformation in a chronic ulcer. The prevalence of malignancy in chronic leg ulcers ranges from 2.0% to 4%. Squamous cell cancer (SCC) and basal cell cancer (BCC) are the most common ulcerating skin tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Spentzouris G, Labropoulos N. The evaluation of lower extremity ulcers. Semin Intervent Radiol. 2009;26:286–95.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Toussaint F, Erdmann M, Berking C, Erfurt-Berge C. Malignant ulcers presenting as chronic leg or foot ulcers. J Clin Med. 2021;10:2252. https://doi.org/10.3390/jcm1012251.

    Article  Google Scholar 

  3. Jacob A. Observations respecting an ulcer of peculiar character, which attacks the eyelids and other parts of the face. Dublin Hosp Represent. 1824;4:232–9.

    Google Scholar 

  4. Asgari MM, Moffet HH, Ray GT, Quesenbery CP. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998-2012. JAMA Dermatol. 2015;151:976–81.

    Article  PubMed  Google Scholar 

  5. Lear W, Dahlke E, Murray CA. Basal cell carcinoma: review of epidemiology, pathogenesis and associated risk factors. J Cutan Med Surg. 2007;11:19–30.

    Article  PubMed  Google Scholar 

  6. Kasumagic-Halilovic E, Hasic M, Ovcina-Kurtoviv N. A clinical study of Basal cell carcinoma. Med Arch. 2019;73:394–8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: a comprehensive review. Bosn J Basic Med Sci. 2018;18:8–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hanna A, Shevde LA. Hedgehog signaling: modulation of cancer properties and tumor microenvironment. Mol Cancer. 2016;15:24.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cameron MC, Lee E, Hibler BP, et al. Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol. 2019;80:303–17.

    Article  PubMed  Google Scholar 

  10. Basset-Seguin N, Herms F. Update on management of basal cell carcinoma. Acta Derm Venereol. 2020;100:adv00140. https://doi.org/10.2340/00015555-3495.

    Article  CAS  PubMed  Google Scholar 

  11. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353:2262–9.

    Article  CAS  PubMed  Google Scholar 

  12. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375:673–85.

    Article  CAS  PubMed  Google Scholar 

  13. Peris K, Fargnoli MC, Garbe C, et al. Diagnosis and treatment of basal cell carcinoma; European consensus based interdisciplinary guidelines. Eur J Cancer. 2019;118:10–34.

    Article  CAS  PubMed  Google Scholar 

  14. Drucker AM, Adam GP, Rofeberg V, et al. Treatment of primary basal cell carcinoma of the skin: a systematic review and network meta-analysis. Ann Intern Med. 2018;169:456–66.

    Article  PubMed  Google Scholar 

  15. Van Loo E, Mosterd K, Krekels GM, et al. Surgical excision versus Mohs’ micrographic surgery for basal cell carcinoma of the face: a randomized clinical trial with 10 years follow-up. Eur J Cancer. 2014;50:3011–20.

    Article  PubMed  Google Scholar 

  16. Nahhas AF, Scarborough CA, Trotter S. A review of the global guidelines on surgical margins for non-melanoma skin cancers. J Clin Aesthet Dermatol. 2017;10:37–46.

    PubMed  PubMed Central  Google Scholar 

  17. Trakatelli M, Morton C, Nagore M, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24:312–29.

    Article  PubMed  Google Scholar 

  18. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159:35–48.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gupta, S.K. (2023). Basal Cell Carcinoma of the Extremity. In: Khanna, A.K., Tiwary, S.K. (eds) Uncommon Ulcers of the Extremities. Springer, Singapore. https://doi.org/10.1007/978-981-99-1782-2_25

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-1782-2_25

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-1781-5

  • Online ISBN: 978-981-99-1782-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics